iShares Biotechnology ETF (IBB)

Delayed Data
As of Feb 06
 -0.98 / -0.72%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to track the investment results of the ICE Biotechnology Index composed of U.S.-listed equities in the biotechnology sector. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

No recent news for iShares Biotechnology ETF.


1 month+4.88% 3 years+5.89%
3 months+6.81% 5 years+4.24%
1 year+5.23% Since inception+6.80%
Data through 02/04/2023

Quote Details

Previous close$136.59
Open day’s range135.26 – 137.27
Net asset value (NAV)136.53 (02/03/2023)
Daily volume1,478,445
Average volume (3 months)1,805,932
Data as of 3:59pm ET, 02/06/2023

Peer Comparisonvs. Health ETFs

Performance 5-yr return+4.24%+7.62%
Expense Gross exp ratio0.44%1.01%
Risk 5 year sharpe ratio0.220.38
Net assets$9.0B$2.0B
Average market cap$21.2B$52.3B
Average P/E16.323.6
Dividend / Share--0.22%


FHLC Fidelity MSCI Health Care Index ETF
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Invesco S&P 500® Equal Weight Health Ca...


Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
GILD Gilead Sciences7.62%
VRTX Vertex Pharmaceuticals Inc7.61%
REGN Regeneron Pharmaceuticals7.15%
AMGN Amgen7.03%
MRNA Moderna Inc5.36%
IQV IQVIA Holdings Inc3.89%
BIIB Biogen3.80%
MTD Mettler-Toledo International Inc3.10%
ILMN Illumina Inc3.09%
ALNY Alnylam Pharmaceuticals Inc2.54%